[EN] COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY<br/>[FR] COMPOSÉS, COMPOSITIONS ET PROCÉDÉS POUR AUGMENTER L'ACTIVITÉ DU CFTR
申请人:PROTEOSTASIS THERAPEUTICS INC
公开号:WO2016105485A2
公开(公告)日:2016-06-30
The present disclosure is directed to disclosed compounds that increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells.